LinkMed the life science entrepreneurs

1
LinkMed the life science entrepreneurs

• Life Science Summit 18 August 2006

2
LinkMeds Mission

• To commercialize new ideas in the life science
  sector by
• Identifying sound business opportunities
• Offering exceptional entrepreneurship
• Providing cutting-edge expertise
• Active involvement in the development of
  companies leading to high-yield exits

3
Opportunities in Swedish Life Sciences

• World-class medical research development
• Unmet financing needs among early-stage companies
• Good conditions for healthy returns

4
Target companies

• Products, not services drug development, medical
  devices, etc.
• More than one product opportunity
• Addressing a large, unmet need in global markets
• Potential to obtain strong IP position
• Possible ownership stake 20 49

5
When investing

• Due diligence scientific as well as market /
  commercial
• Develop an ownership plan based on value drivers
• Targets/ milestones
• Financial needs
• Exit plan
• Assign experienced entrepreneurial management to
  each investment
• Secure a trusting, long-term cooperation with
  inventors and co-investors

Solid foundation for LinkMeds managing owner
concept
6
The managing owner concept
7
Portfolio composition
Life Sciences

• 9 portfolio companies
• 6 biotech
• 3 medtech
• Spread between sectors and therapeutic areas
• Various development stages
• 50 are low to medium risk

8
Portfolio overview BioTech
9
Portfolio overview BioTech
10
Portfolio overview - MedTech
11
Tailored for investment in early life sciences

• A balanced portfolio of companies
• Managing owner concept enhances returns and
  limits risk
• Secures strategic direction
• Tight control of portfolio companies
• Follow-on investments tied to development targets
• Long-term approach to reap the rewards of value
  creation

An unique opportunity to invest in early-stage
life science companies
12
IPO plans

• In connection with IPO, raise capital
• To increase portfolio to 15-20 companies
• Make follow-on investments in maturing companies
• Benefits of a public listing
• A liquid share for shareholders
• Opportunity to use shares as payment in
  transactions
• Visible platform of recognition among
• Inventors and entrepreneurs
• Co-investors
• Potential venture managers

13
Financials

• Income Statement
• 2006 2005 2004 2003
• SEK million Q2 Year Year Year
• Exit result - -0.4 3.0 0.0
• Other income 1.8 3.6 2.2 1.2
• 1.8 3.2 5.2 1.2
• Total costs -7.8 -6.7 -5.1 -4.0
• Net result -6.0 -3.5 0.1 -2.8
• Balance Sheet
• 2006 2005 2004 2003
• SEK million Q1 Year Year Year
• Total assets 112.4 68.2 41.9 27.5
• Shareholders equity 108.5 64.1 38.4 23.1
• Liabilities 3.9 4.1 3.5 4.4

14
Board and owners

• Board of Directors
• Monica Caneman, Chairman
• Agneta Edberg
• Jan Eriksson
• Anders Erlandsson
• Sven-Olof Johansson
• Gunnar Mattsson

• Owners
• FastPartner 22.0
• Koncentra Holding 20.8
• Ingemar Lagerlöf 8.1
• Mannersson Fastigheter 5.6
• Compactor Fastigheter 4.3
• Around 170 others 39.2